2 - 5 September 2018, Basel, Switzerland

The goal of the CLINAM Foundation is to contribute to the benefit of patients and society by exploring and translating leading edge technologies towards clinical application, with an emphasis on Nanomedicine, Targeted Medicine and Precision Medicine. The summit keeps its tradition to build bridges from the enabling technologies to clinical application for major and neglected diseases. There is broad support for this summit by more than 30 collaborating non‐profit institutions.

EUNCL Session at CLINAM:

Parallel 4
34. EU-NCL European Nanomedicine Characterization Laboratory จC Lessons learned

Patrick Boisseau, CEAฉ\Lจฆti, EUNCL infrastructure coordinator, Chairman of the ETPN, Grenoble (F)

10h10 Introduction to EUNCL Patrick Boisseau, CEAฉ\Lจฆti, EUNCL infrastructure coordinator, Chairman of the ETPN, Grenoble (F)
10h25 How to get your nanomedicines processed by EUNCL? Dr. Simon Baconnier, Innovation Project Manager, CEAฉ\Clinatec, Grenoble (F)
10h25 The Regulatorsกฏ Needs; Towards Standardization Dr. Susanne Bremer-Hoffmann (PhD) Team LeaderEuropean Commission Directorate General Joint Research Centre Directorate F จC Health, Consumers and Reference Materials Consumer Products SafetyIspra (VA (I)
10h40 New Frontiers in Characterisation: the Example of Liposomal Irinotecan Nanomedicine Dr. Sven Even Borgos, Research Scientist at SINTEF Materials and Chemistry, Department of Biotechnology and Nanomedicine, Trondheim (N)
Dr. Neill Liptrott, B.Sc., M.Sc., Ph.D., MRSB, Tenure-track Fellow, Nanoimmunotoxicology (Biocompatibility) & Immunopharmacology Nanomedicine Research Group, Dept.t of Molecular and Clinical Pharmacology Institute of Translational Medicine, University of Liverpool (UK)
Patrick Boisseau, CEAฉ\Lจฆti, EUNCL infrastructure coordinator, Chairman of the ETPN, Grenoble (F)
Prof. Dr. Adriele Prina-Mello, PhD, Ussher Assistant Professor / LBCAM Director Trinity Translational Medicine Institute (TTMI) / Department of Clinical Medicine, School of Medicine and AMBER / CRANN, Trinity College Dublin, the University of Dublin (IRL)
Dr. Fanny Caputo, EUNCL responsible of the physical-chemical characterization, CEA Grenoble/LETI/DTBS, Grenoble (F)
11h10 Questions to the entire EUNCL Core Expert Team and Debate  
11h15 End of session  

You will meet:

Patrick Boisseau, CEA

Simon Baconnier, CEA

Ruth Schmidt, SINTEF

Klaus-Michael Weltring, Bioanalytik Muenster

Susanne Bremer-Hoffmann, JRC

Sven-Even Borgos, SINTEF

Neill Liptrott, UL

Fanny Caputo, CEA

Adriele Prina-Mello, TCD

Events where you meet EUNCL

More Events ...

European Nanomedicine Characterisation Laboratory (EUNCL)

Call for Proposals!


  • The JRC is offering a position in the field of immunological safety testing of nanomaterials.
  • European Nanocharacterization laboratory (EUNCL) meets in Münster
    Three years ago, EUNCL was funded as starting community by the European H2020 program with the goal to increase the safety of new nano-based medical products. The representatives and experts from all over Europe met in Münster on May 24th to discuss about the progress in establishing the reference laboratory they set up for the last 3 years and its further development beyond 2019. The partners located in Münster are the only German party involved in EUNCL.
  • Seeking a Formulation Scientist
    The Nanotechnology Characterization Lab (NCL) provides nanotechnology formulation and characterization services for universities, the pharmaceutical industry and other government programs. Since our founding in 2004, the NCL has characterized more than 400 different nanomedicines for more than 100 organizations worldwide. We are currently seeking a Formulation Scientist to join our team. Those having experience with liposomes, micelles, and emulsions are especially encouraged to apply.

More News ...